<p>This figure depicts the cumulative percentage of warfarin-eligible patients (N = 440) who received a prescription for warfarin in the first 30 days following the initial ECG showing atrial fibrillation. The difference between groups was not statistically significant (p = 0.74).</p
Background: Two common indications for oral anticoagulants are patients with non-valvular atrial fi...
ObjectivesThe purpose of this study was to determine both treatment gaps and predictors of warfarin ...
Background: Despite the proven efficacy of warfarin, its use in patients with Atrial Fibrillation (A...
<p>Proportion of anticoagulation therapy (warfarin) in patients within 30 days after atrial fibrilla...
It has been suggested that direct oral anticoagulants are being preferentially used in low risk atri...
<p>* p<0.05</p><p><sup>†</sup> Warfarin-eligible = no active bleeding and no use of warfarin at admi...
We explored associations between INR measures and clinical outcomes in patients with AF using warfar...
BackgroundTime in therapeutic range (TTR) of international normalized ratio (INR) of 2.0 to 3.0 is i...
<p>All patients were followed until an event of cerebral infarction, stroke, death, emigration or en...
AimsTo assess the impact of the introduction of direct oral anticoagulants upon the outcomes from el...
The aim of the study was to evaluate the relationship between the average INR (international normali...
Little is known about prescription trends in atrial fibrillation (AF) in primary health care in Swed...
BACKGROUND: It is unknown whether renal dysfunction conveys poor anticoagulation control in warfarin...
Background—Although warfarin is widely recommended to prevent atrial fibrillation-related thromboemb...
We investigated the spontaneous conversion rate of new-onset atrial fibrillation (AF) in emergency d...
Background: Two common indications for oral anticoagulants are patients with non-valvular atrial fi...
ObjectivesThe purpose of this study was to determine both treatment gaps and predictors of warfarin ...
Background: Despite the proven efficacy of warfarin, its use in patients with Atrial Fibrillation (A...
<p>Proportion of anticoagulation therapy (warfarin) in patients within 30 days after atrial fibrilla...
It has been suggested that direct oral anticoagulants are being preferentially used in low risk atri...
<p>* p<0.05</p><p><sup>†</sup> Warfarin-eligible = no active bleeding and no use of warfarin at admi...
We explored associations between INR measures and clinical outcomes in patients with AF using warfar...
BackgroundTime in therapeutic range (TTR) of international normalized ratio (INR) of 2.0 to 3.0 is i...
<p>All patients were followed until an event of cerebral infarction, stroke, death, emigration or en...
AimsTo assess the impact of the introduction of direct oral anticoagulants upon the outcomes from el...
The aim of the study was to evaluate the relationship between the average INR (international normali...
Little is known about prescription trends in atrial fibrillation (AF) in primary health care in Swed...
BACKGROUND: It is unknown whether renal dysfunction conveys poor anticoagulation control in warfarin...
Background—Although warfarin is widely recommended to prevent atrial fibrillation-related thromboemb...
We investigated the spontaneous conversion rate of new-onset atrial fibrillation (AF) in emergency d...
Background: Two common indications for oral anticoagulants are patients with non-valvular atrial fi...
ObjectivesThe purpose of this study was to determine both treatment gaps and predictors of warfarin ...
Background: Despite the proven efficacy of warfarin, its use in patients with Atrial Fibrillation (A...